Enimmune Market Cap

Enimmune has a market cap or net worth of 1.22 billion as of March 9, 2026. Its market cap has decreased by -35.00% in one year.

Market Cap

1.22B

Enterprise Value

1.12B

Revenue

42.23M

Ranking

n/a

PE Ratio

n/a

Stock Price

17.20

Market Cap Chart

Since September 18, 2018, Enimmune's market cap has decreased from 1.33B to 1.22B, a decrease of -8.23%. That is a compound annual growth rate of -1.14%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	1.24B	-16.26%
Dec 31, 2025	1.49B	-17.27%
Dec 31, 2024	1.80B	-27.21%
Dec 29, 2023	2.47B	-38.63%
Dec 30, 2022	4.02B	69.85%
Dec 30, 2021	2.37B	-11.74%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 26, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GeneReach Biotechnology	1.17B
Great Novel Therapeutics Biotech & Medicals	1.42B
Lukas Biomedical	1.12B
Meribank Biotech	1.45B
Holy Stone Healthcare	1.10B
Abnova (Taiwan)	1.47B
Level Biotechnology	1.10B
NeoCore Technology	1.50B

Market Cap Rankings